Benzinga | Sep 4, 2020 04:30PM EDT

Advaxis Announces Resignation of Chief Financial Officer

PRINCETON, N.J., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced that Molly Henderson, Executive Vice President and Chief Financial Officer, has resigned effective September 25, 2020 to pursue another business opportunity. Kenneth A. Berlin, Advaxis' President and Chief Executive Officer, will serve as interim Chief Financial Officer until a new Chief Financial Officer is appointed.

"We are grateful for Molly's numerous contributions to Advaxis over the past two years," said Kenneth A. Berlin, President and Chief Executive Officer of Advaxis. "Her exceptional leadership and financial stewardship played an important role in allowing the company to focus its resources on, and advance the